Jeff Simmons, CEO of Elanco Animal Health, says the “humanization of pets” is driving growth. He tells Romaine Bostick and Katie Greifeld on “The Close” that Elanco’s new medicine, Canilevia Quattro, is taking significant market share and is the fastest blockbuster in the company’s history. (Source: Bloomberg)
www.bloomberg.com
#Elanco #CEO #GLP1s #Driving #Animal #Protein
Elanco CEO: GLP-1s are Driving Animal Protein Use
